The anticancer activity of propolis

…, H Car, MH Borawska, J Nikliński - Folia Histochemica et …, 2012 - journals.viamedica.pl
… Williams CA, Harborne JB, Newman M, Greenham J, Eagles J. Chrysin and other leaf
exudate … Lapidot T, Walker MD, Kanner J. Antioxidant and prooxidant effects of phenolics on …

MicroRNAs as novel targets and tools in cancer therapy

…, N Patil, JH Leupold, M Moniuszko, J Utikal, J Niklinski… - Cancer letters, 2017 - Elsevier
MicroRNAs (miRNAs) are currently experiencing a renewed peak of attention not only as
diagnostics but also especially as highly promising novel targets or tools for clinical therapy in …

[HTML][HTML] MicroRNA modulators of epigenetic regulation, the tumor microenvironment and the immune system in lung cancer

…, M Abba, A Eljaszewicz, M Moniuszko, J Niklinski… - Molecular cancer, 2015 - Springer
Cancer is an exceedingly complex disease that is orchestrated and driven by a combination
of multiple aberrantly regulated processes. The nature and depth of involvement of …

MicroRNA‐30a inhibits epithelial‐to‐mesenchymal transition by targeting Snai1 and is downregulated in non‐small cell lung cancer

…, S Muppala, M Kozlowski, J Niklinski… - … journal of cancer, 2012 - Wiley Online Library
MicroRNAs (miRNAs) are small non‐coding RNAs which regulate gene expression by base‐pairing
to the 3′‐UTR of the target mRNA. Recently, miRNAs have been shown to …

[HTML][HTML] Molecular signature of subtypes of non-small-cell lung cancer by large-scale transcriptional profiling: identification of key modules and genes by weighted …

…, A Bielska, K Chwialkowska, J Reszec, J Niklinski… - Cancers, 2019 - mdpi.com
Non-small-cell lung cancer (NSCLC) represents a heterogeneous group of malignancies
consisting essentially of adenocarcinoma (ADC) and squamous cell carcinoma (SCC). …

Identification of recurrent FGFR3 fusion genes in lung cancer through kinome‐centred RNA sequencing

…, TR Muley, J Jassem, J Niklinski… - The Journal of …, 2013 - Wiley Online Library
Oncogenic fusion genes that involve kinases have proven to be effective targets for therapy
in a wide range of cancers. Unfortunately, the diagnostic approaches required to identify …

An immune response enriched 72-gene prognostic profile for early-stage non–small-cell lung cancer

P Roepman, J Jassem, EF Smit, T Muley, J Niklinski… - Clinical cancer …, 2009 - AACR
Purpose: Current staging methods are imprecise for predicting prognosis of early-stage non–small-cell
lung cancer (NSCLC). We aimed to develop a gene expression profile for stage I …

[HTML][HTML] Integration of gene dosage and gene expression in non-small cell lung cancer, identification of HSP90 as potential target

…, GA Meijer, WJ Mooi, E Jassem, J Niklinski… - PloS one, 2008 - journals.plos.org
Background Lung cancer causes approximately 1.2 million deaths per year worldwide, and
non-small cell lung cancer (NSCLC) represents 85% of all lung cancers. Understanding the …

[HTML][HTML] Whole genome sequencing puts forward hypotheses on metastasis evolution and therapy in colorectal cancer

…, M Kozlowski, J Reszec, J Niklinski, J Eils… - Nature …, 2018 - nature.com
Incomplete understanding of the metastatic process hinders personalized therapy. Here we
report the most comprehensive whole-genome study of colorectal metastases vs. matched …

[HTML][HTML] MicroRNAs expression profiling of eutopic proliferative endometrium in women with ovarian endometriosis

…, J Szamatowicz, A Charkiewicz, J Niklinski - Reproductive Biology …, 2013 - Springer
Background The eutopic endometrium of women with endometriosis, compared with disease-free
individuals, contains certain molecular alterations, including the differential expression …